15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-α by decreasing levels of acetylated histone H3 and H4 at its promoter

Abstract

Prostaglandin metabolite 15-Deoxy-Δ 12,14 -prostaglandin J2 (15d-PGJ2) is known to inhibit a number of proinflammatory cytokines as well as being a ligand for nuclear receptor PPARγ. We investigated the ability of 15d-PGJ2 to inhibit TNF-α gene expression through mechanisms that involve histone modification. Pretreatment with 15d-PGJ2 at 10 μM inhibited LPS-stimulated TNF-α mRNA in THP-1 monocytes or PMA-differentiated cells to nearly basal levels. A specific PPARγ ligand, GW1929, failed to inhibit LPS-induced TNF-α mRNA expression nor did a PPARγ antagonist, GW9662, alter the repression of TNF-α mRNA in LPS-stimulated cells pretreated with 15d-PGJ2 suggesting a PPARγ-independent inhibition of TNF-α mRNA in THP-1 cells. Transfection studies with a reporter construct and subsequent treatment with 15d-PGJ2 demonstrated a dose-dependent inhibition of the TNF-α promoter. Additional studies demonstrated that inhibition of histone deacetylases with trichostatin A (TSA) or overexpression of histone acetyltransferase CBP could overcome 15d-PGJ2-mediated repression of the TNF-α promoter, suggesting that an important mechanism whereby15d-PGJ2 suppresses a cytokine is through factors that regulate histone modifications. To examine the endogenous TNF-α promoter, chromatin immunoprecipitations (ChIP) were performed. ChIP assays demonstrated that LPS stimulation induced an increase in histone H3 and H4 acetylation at the TNF-α promoter, which was reduced in cells pre-treated with 15d-PGJ2. These results highlight the ability of acetylation and deacetylation factors to affect the TNF-α promoter and demonstrate that an additional important mechanism whereby 15d-PGJ2 mediates TNF-α transcriptional repression by altering levels of acetylated histone H3 and H4 at its promoter.

Cyclooxygenase-2 Induced the β-Amyloid Protein Deposition and Neuronal Apoptosis Via Upregulating the Synthesis of Prostaglandin E2 and 15-Deoxy-Δ12,14-prostaglandin J2

“…For example, anti-inflammatory effects of PGD have now been recognized in leukocytes and other cells, especially after identification of its dehydrated metabolite, 15d-PGJ 2 [65]. 15d-PGJ 2 appeared to be more efficient in reducing the expression of TNF-α in THP-1 monocytes [66]. The observation that a high concentration of 15d-PGJ 2 inhibited the deposition of Aβ raised the question of whether high concentration of 15d-PGJ 2 can improve the cognitive decline of APP/PS1 mice.…”

Ordered transcriptional factor recruitment and epigenetic regulation of tnf-α in necrotizing acute pancreatitis

“…6). In this context, Engdahl et al [53] showed that THP-1 monocytes or PMA-differentiated cells treated with LPS increase histone H3 and H4 acetylation at the TNF-a promoter and that prostaglandin metabolite 15d-PGJ2 is able to block LPS-induced TNF-a expression by decreasing the acetylation level. They also showed that inhibition of HDAC with TSA, or overexpression of CBP, overcomes 15d-PGJ2-mediated repression of the TNF-a promoter.…”

Harnessing peroxisome proliferator-activated receptor γ agonists to induce Heme Oxygenase-1: a promising approach for pulmonary inflammatory disorders

“…Furthermore, PPAR agonists inhibit the activation of genes associated with the inflammatory response, such as IL-2, IL-6, IL-8, TNF-α, and metalloproteases, by modulating signaling pathways involving nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB), activator protein 1 (AP-1), and signal transducer and activator of transcription proteins (STATs) [ 39 ]. The activation of PPARγ also mediates adipogenesis; studies have demonstrated that synthetic PPARγ ligands such as rosiglitazone [ 40 ] and natural ligands such as 15d-PGJ 2 [ 41 ] reduce serum levels and transcription of TNF-α.…”